SlideShare a Scribd company logo
By
Sada Siva,Scientist,
Analytical Development,
Aurobindo Pharma Ltd (Biologics) .
Analytical Method Validation
Analytical Method life cycle
4.Method Validation
To prove method has the ability to
perform for its intendted use
complete Documentation
3. Method Transfer to QC
Method transfer to end user /clients
5. Periodically Monitoring / Review
of Methods in Control Labs
1. Analytical method development
To optimize a method for intended use
2. Qualification of method
To prove method has the ability to
perform for its intended use
Intial Documentation
6. Method Revalidation
If any changes in method / method
perfomance changes with time
Validation-Introduction
 What
 Why
 Where
 Who
 When
 How
 Requirements
 Case study
What is a validation?
 It is a process of demonstrating that method is
suitable their intended use with documentation.
 Validation should verify the suitability of an analytical
method for its intended purpose
 Validation may be performed in different ways
(individual purpose) according to common
standards/guidelines
Why do we need to do validation?
Regulatory bodies require safety and quality information
of our product for approvals.
For this one should need to have reliable test methods.
That reliability of method is provided by doing a
validation exercise ., and which is documented.
*It is also essential part of GMP practices
Where , when & who will perform
Validation ?
 Where:
Generally validation is performed in a GxP laboratory
or Equivalent.
mostly it should be performed in End user (QC)
laboratory where the method going to be used
regularly.
 Who:
A qualified analyst (GxP trained, qualified and skilled )
 When:
Before commercialization (during CT3 time-
biosimilars )
Before CT or IND application ( for New Drugs)
Pre-requisites of validation?
 Prerequisites for analytical method validation
 Six “M”s
Ready to start
Validation
Man Machine
qualified
calibrated
robust
qualified
Methods
suitable
characterised
documented
MilieuMaterial Management
Quality
Reference
standards
Tempe-
rature
Analysts´
support
skilled
Humidity
Vibrations Time
Supplies
Irradi-
ations
How to perform validation?
 Many regulatory bodies have guideline how to perform
validation of analytical method.
 Some of them are ICH Q2, FDA, USP, EMEA
Validation characteristics (parameters)
 Accuracy
 Specificity
 Precision
Repeatability
Intermediate precision
Reproducibility
 Linearity
 Limit of detection
 Limit of quantitation
 Range
 Robustness
Degree of validation depends on Test
System suitability and Acceptance
criteria
 Integral part of each method/procedure to ensure that
all analytical operations, electronics and equipment's
are working properly at the time of analysis.
 Appropriate system suitability and its acceptance
criteria should be defined.
 Resolution ,tailing factor, RRT , capacity factor, no . of
theoretical plates between 2 peaks in chromatography
methods
 Minimum height /response of control samples
 Spike recovery in sample processing (extraction) is there.
 BC recovery of known amount of control sample
 In every parameter it should comply or pass if not the test
will be considered (not used)
Specificity
 Specificity Is the ability to assess unequivocally the
analyte in the presence of components which may be
expected to be present (impurities, degradants,
matrix…)
Identity testing
 To ensure the identity of an analyte
Purity testing
 To ensure accurate statement on the content of
impurities of an analyte
Assay
 To allow an accurate statement on the content of an
analyte in a sample
Specificity-Approaches
 Selectivity: the extent to which a method can determine
particular analyses in mixtures in matrix without interference
from other compounds (used in chemistry but in specificity
is the ultimate of selectivity-IUPAC)
SAMPLE PURPOSE
SYSTEM SUITABILITY SAMPLE SYSTEM SUITABILITY
FORMULATION BUFFER (SEC,CEX)
TO EVALUATE MATRIX
INTERFERENCE OR
TO EVALUATE
SEPARATION
SELECTIVITY
TEST SAMPLE DILUTED IN FB, WFI (OD 280,SEC)
TEST SAMPLE
TEST SAMPLE SPIKED WITH IMPURITY (HCD)
IMPURITY SAMPLE NEAT (HCP,HCD)
UNRELATED SAMPLES (GLYCAN, SDS-
PAGE,HCD)
SYSTEM SUITABILITY SAMPLE SYSTEM SUITABILITY
Precision
• Expresses the closeness of agreement between a
series of measurements (replicates) obtained from
multiple sampling(different vials) of the same
homogenous sample (same batch)
• Is usually expressed as the standard deviation
(S), variance (S2) or relative standard deviation
(RSD) of a series of measurements
• Precision may be considered at three levels
 Repeatability (intra-assay precision)
 Intermediate Precision (variability within a laboratory)
 Reproducibility (precision between laboratories)
Repeatability-Approaches
 Repeating the analysis under same operating conditions in a short
time interval
 Same samples analysis(different vials from same batch) in same
sequence.
 Independent sample preparations (6) will be done but analysed in a
single assay.
Sample Name HMW Peak
RT Area % of Area
System suitability sample 3.24 58481 0.88
Test sample Replicate 1 3.24 109382 1.59
Test sample Replicate 2 3.24 109560 1.58
Test sample Replicate 3 3.24 110185 1.58
Test sample Replicate 4 3.24 108539 1.58
Test sample Replicate 5 3.24 109996 1.59
Test sample Replicate 6 3.24 110362 1.59
Test sample con 1(triplicates)
concentration based precision (3 replicate / 3
different concentration)
Test sample con 2 (triplicates)
Test sample con 3 (triplicates)
%RSD 0.00 1 0.17
Intermediate Precision-
Approaches
 Same test sample is analysed varying any one
test condition like analyst , Day, Instrument,
reagents/consumables of different lots etc.
Sample Name HMW Impurity
RT Area % of Area
Test sample _Ctrl 3.24 109670 1.58
Test sample_Inter instrument 3.24 109851 1.31
Test sample_Inter analyst 3.24 120053 1.49
Test sample_Interday 3.24 116089 1.53
P2_Test sample_Inter column 3.26 113579 1.57
%RSD 0.21 4 7.39
Reproducibility
 Precision between two laboratories.
 Interlab precision.
 Generally done in labs working with collaboration /
pharmacopeia methods
 Generally not required in industries.
 Ruggedness (USP) is defined as the degree of
reproducibility of results under variety of conditions like
different labs, Environmental conditions, materials ,
operators, instruments and analysts.
Robustness – deliberate changes in operations conditions
Ruggedness-normal , expected operations conditions (many
labs)
Reproducibility- normal operations conditions in 2 or 3 labs
(clients)
Accuracy
• Expresses the closeness of agreement between
the value which is accepted either as a
conventional true value (Expected) or an
accepted reference value and the value found
(Observed value by method)
 Sometimes referred to as „TRUENESS“/ Sameness
 Agreement of test results with the true value
 Expressed in % Recovery
Accuracy- Approaches
 Spiking known amount in sample (HCD,SEC) and
calculating the spike recovery (3 conc /3 replicates)
 Spiking of ref.mateterial in placebo.
 Known amount (purity) of sample is taken and
analysed to check method recovery(80-120%
acceptable range )
sample Expected Observed % Recovery
sample-1 100 98 98
sample-2 80 81 101
sample-3 20 19 95
Precision and Accuracy
Accurate &
precise Accurate &
imprecise Inaccurate &
precise Inaccurate &
imprecise
Linearity
 Linearity of an analytical procedure is its ability (within a
given range) to obtain test results which are directly
proportional to the concentration (amount) of analyte in
the sample
 If there is a linear relationship, test results should be
evaluated by appropriate statistical methods
 Correlation coefficient (r)
 Y-intercept
 Slope of regression line
 Residual sum of squares (R2)
 Plot of recovey
Linearity Approaches
 Different con (minimum 5) of sample Vs responses
(PAHPLC,OD 280,HCD)
 Spiking of known amount of impurity/substances into
test sample (SEC ,CEX, Glycan)
Range
 Range
The range of an analytical procedure is the interval between the
upper and lower concentration (amounts) of analyte in the sample
for which it has been demonstrated that the analytical procedure
has a suitable level of precision, accuracy and linearity
Range-Approaches
 Data from linearity/accuracy is used to check this.
 Have to check how method behaves in different ranges like
Ex: Complete range of method used in linearity (0.1 to 120 %)
Lower range of linearity/accuracy samples (0.1 to 10%)
Middle range of linearity/accuracy samples (10 to 100%)
Higher range of linearity/accuracy samples (50-120%)
Limit of Quantitation (LOQ, QL)
 Limit of Quantitation (LOQ, QL)
 The LOQ is the lowest amount of analyte in a sample
which can be quantitatively determined with suitable
precision and accurac
 Determination is usually based on
 Signal to noise ratio (~10:1) (baseline noise)
-- Standard deviation of response (s) and Slope (S)
 Viaual evaluation
 Calibration curve
 SD of blanks
Limit of Detection (LOD, DL)
 Limit of Detection (LOD, DL)
 The LOD of an analytical procedure is the lowest
amount of analyte in sample which can be detected
but not necessarily quantitated as an exact value
 Determination is usually based on
 Signal to noise ratio (~3:1) (baseline noise)
 Standard deviation of response (s) and Slope (S)
 Viaual evaluation
 Calibration curve
 SD of blanks
LOD and LOQ calculations
Robustness
 Robustness
 Robustness of an analytical procedure should
show the reliability of an analysis with respect to
deliberate variations in method parameters
 The evaluation of robustness should be
considered during the development phase
Robustness-Approaches
 Deliberate changes like reagents/buffers pH,
concentration, temperature, injection volume,
Incubation time , Samples stability, pippete errors
etc depending on type of methods
If measurements are susceptible to variations in
analytical conditions the analytical conditions
should be suitably controlled or a precautionary
statement should be included in the procedure
Verification of Reference Method
or pharmacopeia method
 The suitability of compendial method must be verified that they
are suitable for the DS/DP analysis in that laboratory conditions
following characteristics should be checked.
 Specificity
 Intermediate precision
 Stability of samples solution (defined if critical)
Revalidation consideration
 To Repeat validation of an validated method to
ensure continued compliance with established
requirements after a defined time or in following
situations.
Found that Method performance changes with time
Where some changes were made for improvement in
 Method ,
 Process ,
 DP formulation
 Product etc.
 Degree of validation depends on type of change/ its
criticality
Adjustments Vs Changes
Other consideration
 When using a non- pharmacopeia method
(justification is needed, comparison with
Pha.method,complete validation required )
 Stress studies should demonstrate that impurities
and degradents from the sample do not interfere with
the quantitation of sample.
References
 ICH Q2: validation of analytical procedures, Text and
methodology
 USP: validation of compendial method
 FDA :Analytical procedures and methods validation (Guidance
for industry-draft guidance)
 Emea : recommends to follow ICH Q 2
 WHO :supplementary guidelines on GMP :validation Annexure 2
: Analytical method validation
 Book: validation of analytical method from agilent technologies
 Book: Method validation in pharmaceutical analysis by j.Ermer
and J.H.mill
Learning starts from questioning
??????????
Learning is a continuous process
For giving this opportunity
Have A Nice Weekend

More Related Content

PPTX
PDF
ICH GUIDELINES QSEM
PDF
PPTX
validation and calibration of HPLC
PPTX
Quality as a strategic decision
PDF
Process validation
PPTX
cGMP Guidelines According to Schedule M
PPTX
Analytical method validation
ICH GUIDELINES QSEM
validation and calibration of HPLC
Quality as a strategic decision
Process validation
cGMP Guidelines According to Schedule M
Analytical method validation

What's hot (20)

PPTX
USFDA guidelines for bioanalytical method validation
PPTX
MHRA Data Integrity Requirements
PPTX
Thermal techniques- DSC- Durgashree Diwakar
PPTX
Process validation
PPT
EQUIPMENT VALIDATION
PPTX
Calibaration and validation of hplc
PPT
Analytical methods validation as per ich & usp
PPTX
Developing specifications q3 q6
PPT
Analytical validation
PPTX
21 Code of Federal Regulation(21-CFR)
PPTX
HPLC Trouble Shotting
PPTX
PPTX
Bulk active post approval changes
PPTX
Bioanalytical Method Validation
PDF
Ich q10
PPTX
System suitability testing
PPTX
Out of Specification OOS.pptx
PPTX
Method Validation - Linearity
PPTX
Experimental parameters of DSC
USFDA guidelines for bioanalytical method validation
MHRA Data Integrity Requirements
Thermal techniques- DSC- Durgashree Diwakar
Process validation
EQUIPMENT VALIDATION
Calibaration and validation of hplc
Analytical methods validation as per ich & usp
Developing specifications q3 q6
Analytical validation
21 Code of Federal Regulation(21-CFR)
HPLC Trouble Shotting
Bulk active post approval changes
Bioanalytical Method Validation
Ich q10
System suitability testing
Out of Specification OOS.pptx
Method Validation - Linearity
Experimental parameters of DSC
Ad

Similar to Analytical mehod validation explained sadasiva (20)

PPTX
Analytical method validation
PPT
Analytical method validation
PPTX
Method Selection - Selection of a prospective method for day to day laborator...
PDF
Analytical Method Validation basics by Dr. A. Amsavel
PPTX
'Validation of system Protocol for Students'.pptx
PPTX
Analytical Method Validation.pptx
PPTX
Analytical method validation
PPTX
Analytical Method Validations & Detailed Method Validation Parameters
PDF
Validation of Analytical Procedures.pdf
PPT
analytical method validation and validation of hplc
PDF
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
DOCX
All you know About Analytical method validation
PPT
Evaluation of methods in clinical laboratory
PPTX
Analytical method validation as per ich and usp
PDF
Usp chemical medicines & excipients - evolution of validation practices
PPTX
Accuracy and precision presentation
PPTX
Ich guidelines for validation final
PPTX
Analytical Method Validation
PPTX
Analytical Methods Validation| PV M Pharmacy QA
PPTX
Pharmacy Slideshow XL by Slidesgo.pptx
Analytical method validation
Analytical method validation
Method Selection - Selection of a prospective method for day to day laborator...
Analytical Method Validation basics by Dr. A. Amsavel
'Validation of system Protocol for Students'.pptx
Analytical Method Validation.pptx
Analytical method validation
Analytical Method Validations & Detailed Method Validation Parameters
Validation of Analytical Procedures.pdf
analytical method validation and validation of hplc
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
All you know About Analytical method validation
Evaluation of methods in clinical laboratory
Analytical method validation as per ich and usp
Usp chemical medicines & excipients - evolution of validation practices
Accuracy and precision presentation
Ich guidelines for validation final
Analytical Method Validation
Analytical Methods Validation| PV M Pharmacy QA
Pharmacy Slideshow XL by Slidesgo.pptx
Ad

Recently uploaded (20)

PDF
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
PPTX
community services team project 2(4).pptx
PPTX
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
PPTX
First Aid and Basic Life Support Training.pptx
PPTX
BLS, BCLS Module-A life saving procedure
PPTX
Infection prevention and control for medical students
PPTX
CBT FOR OCD TREATMENT WITHOUT MEDICATION
PDF
Dr Masood Ahmed Expertise And Sucess Story
PDF
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
PDF
Megan Miller Colona Illinois - Passionate About CrossFit
PDF
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
PDF
Dr. Jasvant Modi - Passionate About Philanthropy
PDF
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
PPTX
Immunity....(shweta).................pptx
PDF
DAY-6. Summer class. Ppt. Cultural Nursing
PPTX
1. Drug Distribution System.pptt b pharmacy
PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
PPTX
Basics of pharmacology (Pharmacology I).pptx
PPTX
COMMUNICATION SKILSS IN NURSING PRACTICE
PPT
Recent advances in Diagnosis of Autoimmune Disorders
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
community services team project 2(4).pptx
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
First Aid and Basic Life Support Training.pptx
BLS, BCLS Module-A life saving procedure
Infection prevention and control for medical students
CBT FOR OCD TREATMENT WITHOUT MEDICATION
Dr Masood Ahmed Expertise And Sucess Story
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
Megan Miller Colona Illinois - Passionate About CrossFit
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
Dr. Jasvant Modi - Passionate About Philanthropy
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
Immunity....(shweta).................pptx
DAY-6. Summer class. Ppt. Cultural Nursing
1. Drug Distribution System.pptt b pharmacy
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
Basics of pharmacology (Pharmacology I).pptx
COMMUNICATION SKILSS IN NURSING PRACTICE
Recent advances in Diagnosis of Autoimmune Disorders

Analytical mehod validation explained sadasiva

  • 1. By Sada Siva,Scientist, Analytical Development, Aurobindo Pharma Ltd (Biologics) . Analytical Method Validation
  • 2. Analytical Method life cycle 4.Method Validation To prove method has the ability to perform for its intendted use complete Documentation 3. Method Transfer to QC Method transfer to end user /clients 5. Periodically Monitoring / Review of Methods in Control Labs 1. Analytical method development To optimize a method for intended use 2. Qualification of method To prove method has the ability to perform for its intended use Intial Documentation 6. Method Revalidation If any changes in method / method perfomance changes with time
  • 3. Validation-Introduction  What  Why  Where  Who  When  How  Requirements  Case study
  • 4. What is a validation?  It is a process of demonstrating that method is suitable their intended use with documentation.  Validation should verify the suitability of an analytical method for its intended purpose  Validation may be performed in different ways (individual purpose) according to common standards/guidelines
  • 5. Why do we need to do validation? Regulatory bodies require safety and quality information of our product for approvals. For this one should need to have reliable test methods. That reliability of method is provided by doing a validation exercise ., and which is documented. *It is also essential part of GMP practices
  • 6. Where , when & who will perform Validation ?  Where: Generally validation is performed in a GxP laboratory or Equivalent. mostly it should be performed in End user (QC) laboratory where the method going to be used regularly.  Who: A qualified analyst (GxP trained, qualified and skilled )  When: Before commercialization (during CT3 time- biosimilars ) Before CT or IND application ( for New Drugs)
  • 7. Pre-requisites of validation?  Prerequisites for analytical method validation  Six “M”s Ready to start Validation Man Machine qualified calibrated robust qualified Methods suitable characterised documented MilieuMaterial Management Quality Reference standards Tempe- rature Analysts´ support skilled Humidity Vibrations Time Supplies Irradi- ations
  • 8. How to perform validation?  Many regulatory bodies have guideline how to perform validation of analytical method.  Some of them are ICH Q2, FDA, USP, EMEA
  • 9. Validation characteristics (parameters)  Accuracy  Specificity  Precision Repeatability Intermediate precision Reproducibility  Linearity  Limit of detection  Limit of quantitation  Range  Robustness
  • 10. Degree of validation depends on Test
  • 11. System suitability and Acceptance criteria  Integral part of each method/procedure to ensure that all analytical operations, electronics and equipment's are working properly at the time of analysis.  Appropriate system suitability and its acceptance criteria should be defined.  Resolution ,tailing factor, RRT , capacity factor, no . of theoretical plates between 2 peaks in chromatography methods  Minimum height /response of control samples  Spike recovery in sample processing (extraction) is there.  BC recovery of known amount of control sample  In every parameter it should comply or pass if not the test will be considered (not used)
  • 12. Specificity  Specificity Is the ability to assess unequivocally the analyte in the presence of components which may be expected to be present (impurities, degradants, matrix…) Identity testing  To ensure the identity of an analyte Purity testing  To ensure accurate statement on the content of impurities of an analyte Assay  To allow an accurate statement on the content of an analyte in a sample
  • 13. Specificity-Approaches  Selectivity: the extent to which a method can determine particular analyses in mixtures in matrix without interference from other compounds (used in chemistry but in specificity is the ultimate of selectivity-IUPAC) SAMPLE PURPOSE SYSTEM SUITABILITY SAMPLE SYSTEM SUITABILITY FORMULATION BUFFER (SEC,CEX) TO EVALUATE MATRIX INTERFERENCE OR TO EVALUATE SEPARATION SELECTIVITY TEST SAMPLE DILUTED IN FB, WFI (OD 280,SEC) TEST SAMPLE TEST SAMPLE SPIKED WITH IMPURITY (HCD) IMPURITY SAMPLE NEAT (HCP,HCD) UNRELATED SAMPLES (GLYCAN, SDS- PAGE,HCD) SYSTEM SUITABILITY SAMPLE SYSTEM SUITABILITY
  • 14. Precision • Expresses the closeness of agreement between a series of measurements (replicates) obtained from multiple sampling(different vials) of the same homogenous sample (same batch) • Is usually expressed as the standard deviation (S), variance (S2) or relative standard deviation (RSD) of a series of measurements • Precision may be considered at three levels  Repeatability (intra-assay precision)  Intermediate Precision (variability within a laboratory)  Reproducibility (precision between laboratories)
  • 15. Repeatability-Approaches  Repeating the analysis under same operating conditions in a short time interval  Same samples analysis(different vials from same batch) in same sequence.  Independent sample preparations (6) will be done but analysed in a single assay. Sample Name HMW Peak RT Area % of Area System suitability sample 3.24 58481 0.88 Test sample Replicate 1 3.24 109382 1.59 Test sample Replicate 2 3.24 109560 1.58 Test sample Replicate 3 3.24 110185 1.58 Test sample Replicate 4 3.24 108539 1.58 Test sample Replicate 5 3.24 109996 1.59 Test sample Replicate 6 3.24 110362 1.59 Test sample con 1(triplicates) concentration based precision (3 replicate / 3 different concentration) Test sample con 2 (triplicates) Test sample con 3 (triplicates) %RSD 0.00 1 0.17
  • 16. Intermediate Precision- Approaches  Same test sample is analysed varying any one test condition like analyst , Day, Instrument, reagents/consumables of different lots etc. Sample Name HMW Impurity RT Area % of Area Test sample _Ctrl 3.24 109670 1.58 Test sample_Inter instrument 3.24 109851 1.31 Test sample_Inter analyst 3.24 120053 1.49 Test sample_Interday 3.24 116089 1.53 P2_Test sample_Inter column 3.26 113579 1.57 %RSD 0.21 4 7.39
  • 17. Reproducibility  Precision between two laboratories.  Interlab precision.  Generally done in labs working with collaboration / pharmacopeia methods  Generally not required in industries.  Ruggedness (USP) is defined as the degree of reproducibility of results under variety of conditions like different labs, Environmental conditions, materials , operators, instruments and analysts. Robustness – deliberate changes in operations conditions Ruggedness-normal , expected operations conditions (many labs) Reproducibility- normal operations conditions in 2 or 3 labs (clients)
  • 18. Accuracy • Expresses the closeness of agreement between the value which is accepted either as a conventional true value (Expected) or an accepted reference value and the value found (Observed value by method)  Sometimes referred to as „TRUENESS“/ Sameness  Agreement of test results with the true value  Expressed in % Recovery
  • 19. Accuracy- Approaches  Spiking known amount in sample (HCD,SEC) and calculating the spike recovery (3 conc /3 replicates)  Spiking of ref.mateterial in placebo.  Known amount (purity) of sample is taken and analysed to check method recovery(80-120% acceptable range ) sample Expected Observed % Recovery sample-1 100 98 98 sample-2 80 81 101 sample-3 20 19 95
  • 20. Precision and Accuracy Accurate & precise Accurate & imprecise Inaccurate & precise Inaccurate & imprecise
  • 21. Linearity  Linearity of an analytical procedure is its ability (within a given range) to obtain test results which are directly proportional to the concentration (amount) of analyte in the sample  If there is a linear relationship, test results should be evaluated by appropriate statistical methods  Correlation coefficient (r)  Y-intercept  Slope of regression line  Residual sum of squares (R2)  Plot of recovey
  • 22. Linearity Approaches  Different con (minimum 5) of sample Vs responses (PAHPLC,OD 280,HCD)  Spiking of known amount of impurity/substances into test sample (SEC ,CEX, Glycan)
  • 23. Range  Range The range of an analytical procedure is the interval between the upper and lower concentration (amounts) of analyte in the sample for which it has been demonstrated that the analytical procedure has a suitable level of precision, accuracy and linearity
  • 24. Range-Approaches  Data from linearity/accuracy is used to check this.  Have to check how method behaves in different ranges like Ex: Complete range of method used in linearity (0.1 to 120 %) Lower range of linearity/accuracy samples (0.1 to 10%) Middle range of linearity/accuracy samples (10 to 100%) Higher range of linearity/accuracy samples (50-120%)
  • 25. Limit of Quantitation (LOQ, QL)  Limit of Quantitation (LOQ, QL)  The LOQ is the lowest amount of analyte in a sample which can be quantitatively determined with suitable precision and accurac  Determination is usually based on  Signal to noise ratio (~10:1) (baseline noise) -- Standard deviation of response (s) and Slope (S)  Viaual evaluation  Calibration curve  SD of blanks
  • 26. Limit of Detection (LOD, DL)  Limit of Detection (LOD, DL)  The LOD of an analytical procedure is the lowest amount of analyte in sample which can be detected but not necessarily quantitated as an exact value  Determination is usually based on  Signal to noise ratio (~3:1) (baseline noise)  Standard deviation of response (s) and Slope (S)  Viaual evaluation  Calibration curve  SD of blanks
  • 27. LOD and LOQ calculations
  • 28. Robustness  Robustness  Robustness of an analytical procedure should show the reliability of an analysis with respect to deliberate variations in method parameters  The evaluation of robustness should be considered during the development phase
  • 29. Robustness-Approaches  Deliberate changes like reagents/buffers pH, concentration, temperature, injection volume, Incubation time , Samples stability, pippete errors etc depending on type of methods If measurements are susceptible to variations in analytical conditions the analytical conditions should be suitably controlled or a precautionary statement should be included in the procedure
  • 30. Verification of Reference Method or pharmacopeia method  The suitability of compendial method must be verified that they are suitable for the DS/DP analysis in that laboratory conditions following characteristics should be checked.  Specificity  Intermediate precision  Stability of samples solution (defined if critical)
  • 31. Revalidation consideration  To Repeat validation of an validated method to ensure continued compliance with established requirements after a defined time or in following situations. Found that Method performance changes with time Where some changes were made for improvement in  Method ,  Process ,  DP formulation  Product etc.  Degree of validation depends on type of change/ its criticality
  • 33. Other consideration  When using a non- pharmacopeia method (justification is needed, comparison with Pha.method,complete validation required )  Stress studies should demonstrate that impurities and degradents from the sample do not interfere with the quantitation of sample.
  • 34. References  ICH Q2: validation of analytical procedures, Text and methodology  USP: validation of compendial method  FDA :Analytical procedures and methods validation (Guidance for industry-draft guidance)  Emea : recommends to follow ICH Q 2  WHO :supplementary guidelines on GMP :validation Annexure 2 : Analytical method validation  Book: validation of analytical method from agilent technologies  Book: Method validation in pharmaceutical analysis by j.Ermer and J.H.mill
  • 35. Learning starts from questioning ??????????
  • 36. Learning is a continuous process For giving this opportunity Have A Nice Weekend